Market Overview:

The global mycotoxin testing market size was valued at USD 1.23 billion in 2023. The market is projected to grow from USD 1.32 billion in 2024 to USD 2.40 billion by 2032, exhibiting a CAGR of 7.69% during the forecast period.

Mycotoxins, chemical compounds from fungi, present risks in food and feed grains, potentially causing diseases in humans and animals. Increased internet accessibility and ongoing research efforts by experts and biotechnologists are raising awareness about foodborne illnesses and the importance of mycotoxin testing, driving market demand.

The COVID-19 pandemic disrupted the food and feed supply chain, causing border closures and production site shutdowns, resulting in decreased global production and trade. Closure of the food service industry and losses in the non-food retail sector further contributed to a decline in revenue, reflecting the overall impact of the pandemic on the market.

Fortune Business Insights™ provides this information in its research report, titled “Mycotoxin TestingMarket, 2024-2032”.

List of Key Players Mentioned in the Report:

• ALS Limited (Australia)
• Bureau Veritas (France)
• Charm Sciences, Inc. (U.S.)
• EMSL Analytical, Inc. (U.S.)
• IEH Laboratories and Consulting Group (U.S.)
• Intertek Group PLC Solutions (U.K.)
• Krishgen BioSystems (India)
• PerkinElmer, Inc. (U.S.)
• Premier Analytical Services (U.K.)
• SGS S.A. (Switzerland)

Source: https://www.fortunebusinessinsights.com/mycotoxin-testing-market-106204

Segmentation:

AflatoxinSegment Secures the Largest Market Share owing to Widespread Presence in Key Food Products

On the basis of pathogen type, the market is classified into Aflatoxin, Patulin, Zearalenone, Fumonisins, Ochratoxins, Deoxynivalenol, and others. Aflatoxin's prevalence in a variety of food products such as groundnuts, tree nuts, maize, rice, figs, and spices drives demand for extensive testing, contributing to its largest market share.